Long non-coding RNAs (lncRNAs) are emerging as essential regulators of gene expression, but their role in normal and neoplastic B cells is still largely uncharacterized. Here, we report on the expression pattern of the LINC00152 in normal B cells and Chronic Lymphocytic Leukemia B cell clones. Higher LINC00152 levels were consistently observed in memory B cell populations when compared to naïve B cells in the normal tissues analyzed [peripheral blood (PB), tonsils, and spleen]. In addition, independent stimulation via Immunoglobulins (IG), CD40, or Toll-like Receptor 9 (TLR9) upregulated LINC00152 in PB B cells. The expression of LINC00152 in a cohort of 107 early-stage Binet A CLL patients was highly variable and did not correlate with known prognostic markers or clinical evolution. TLR9 stimulation, but not CD40 or IG challenge, was able to upregulate LINC00152 expression in CLL cells. However, LINC00152 silencing in CLL cell lines expressing LINC00152 failed to induce significant cell survival or apoptosis changes. These data suggest that, in normal B cells, the expression of LINC00152 is regulated by immunomodulatory signals, which are only partially effective in CLL cells. However, LINC00152 does not appear to contribute to CLL cell expansion and/or survival in a cohort of newly diagnosed CLL patients.
LINC00152 expression in normal and chronic lymphocytic leukemia B cells / S. Matis, M. Rossi, L. Brondolo, M. Cardillo, D. Reverberi, R. Massara, M. Colombo, A. Ibatici, E. Angelucci, T. Vaisitti, S. Bruno, S. Fabris, A. Neri, M. Gentile, F. Morabito, G. Cutrona, P. Briata, R. Gherzi, F. Fais. - In: HEMATOLOGICAL ONCOLOGY. - ISSN 0278-0232. - (2021 Oct 22). [Epub ahead of print] [10.1002/hon.2938]
LINC00152 expression in normal and chronic lymphocytic leukemia B cells
S. Fabris;A. Neri;
2021
Abstract
Long non-coding RNAs (lncRNAs) are emerging as essential regulators of gene expression, but their role in normal and neoplastic B cells is still largely uncharacterized. Here, we report on the expression pattern of the LINC00152 in normal B cells and Chronic Lymphocytic Leukemia B cell clones. Higher LINC00152 levels were consistently observed in memory B cell populations when compared to naïve B cells in the normal tissues analyzed [peripheral blood (PB), tonsils, and spleen]. In addition, independent stimulation via Immunoglobulins (IG), CD40, or Toll-like Receptor 9 (TLR9) upregulated LINC00152 in PB B cells. The expression of LINC00152 in a cohort of 107 early-stage Binet A CLL patients was highly variable and did not correlate with known prognostic markers or clinical evolution. TLR9 stimulation, but not CD40 or IG challenge, was able to upregulate LINC00152 expression in CLL cells. However, LINC00152 silencing in CLL cell lines expressing LINC00152 failed to induce significant cell survival or apoptosis changes. These data suggest that, in normal B cells, the expression of LINC00152 is regulated by immunomodulatory signals, which are only partially effective in CLL cells. However, LINC00152 does not appear to contribute to CLL cell expansion and/or survival in a cohort of newly diagnosed CLL patients.File | Dimensione | Formato | |
---|---|---|---|
Matis_Hematol Oncol_2021_Epub.pdf
accesso aperto
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
176.39 kB
Formato
Adobe PDF
|
176.39 kB | Adobe PDF | Visualizza/Apri |
hon.2938.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
577.83 kB
Formato
Adobe PDF
|
577.83 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.